|
1
|
Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed.
|
Epidemiology
|
1999
|
2.12
|
|
2
|
Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study.
|
BMJ
|
1999
|
1.99
|
|
3
|
A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom.
|
Pharmacotherapy
|
1997
|
1.55
|
|
4
|
Rheumatoid arthritis in UK primary care: incidence and prior morbidity.
|
Scand J Rheumatol
|
2009
|
1.55
|
|
5
|
[Osteoarticular disorders in the elderly: an approach to their population impact].
|
Med Clin (Barc)
|
1996
|
1.50
|
|
6
|
Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease.
|
Aliment Pharmacol Ther
|
2010
|
1.49
|
|
7
|
Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome.
|
Scand J Gastroenterol
|
2000
|
1.32
|
|
8
|
Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?
|
Epidemiology
|
1997
|
1.30
|
|
9
|
Incidence of newly diagnosed heart failure in UK general practice.
|
Eur J Heart Fail
|
2001
|
1.08
|
|
10
|
Incidence rates and trends of hip/femur fractures in five European countries: comparison using e-healthcare records databases.
|
Calcif Tissue Int
|
2014
|
0.96
|
|
11
|
Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs?
|
Aliment Pharmacol Ther
|
2003
|
0.91
|
|
12
|
Unmet health care needs and mortality among Spanish elderly.
|
Am J Public Health
|
1997
|
0.90
|
|
13
|
Comparison of mortality from peptic ulcer bleed between patients with or without peptic ulcer antecedents.
|
Epidemiology
|
1998
|
0.82
|
|
14
|
Unspecified abdominal pain in primary care: the role of gastrointestinal morbidity.
|
Int J Clin Pract
|
2007
|
0.78
|
|
15
|
Health resource utilization and drug treatment pattern in a cohort of patients with a first episode of gastroesophageal reflux disease.
|
Pharmacoepidemiol Drug Saf
|
1999
|
0.75
|